Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 4, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.63B
sum of reported positions
Reported positions
182
Changes vs prior quarter
117
10 new · 7 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 324 measured positions in 8 quarters, the typical new or larger position finished −2.6 pts against the S&P 500 and 43% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 307K | $133M | 2.4% | |
TEVA PHARMACEUTICAL INDS LTD | 3.79M | $128M | 2.3% |
| 371K | $126M | 2.2% | |
| 417K | $117M | 2.1% |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $5.11B | $5.63B |
| Positions | 179 | 182 |
| Biggest line | — | Dell Technologies 2% |
| 361K | $109M | 1.9% |
| 218K | $104M | 1.9% |
| 256K | $91.5M | 1.6% |
| 6.51M | $89.9M | 1.6% |
| 2.73M | $85.8M | 1.5% |
| 1.1M | $85.6M | 1.5% |
| 877K | $83.2M | 1.5% |
| 1.04M | $80.9M | 1.4% |
| 5.35M | $80.5M | 1.4% |
| 4.03M | $80.1M | 1.4% |
| 383K | $80.1M | 1.4% |
| 244K | $79.9M | 1.4% |
| 200K | $76.9M | 1.4% |
| 200K | $75.4M | 1.3% |
| 1.07M | $75.3M | 1.3% |
| 517K | $75.3M | 1.3% |
| 66K | $74.6M | 1.3% |
| 104K | $74.3M | 1.3% |
| 2.68M | $72M | 1.3% |
| 282K | $71.1M | 1.3% |
| 62K | $71M | 1.3% |
Kb Financial Group (KB)
557K → 551K shares (−1%)
BorgWarner (BWA)
720K → 845K shares (+17%)
Parker Hannifin (PH)
56K → 57K shares (+2%)
Gen Digital (GEN)
1.53M → 2.18M shares (+42%)
Gilead Sciences (GILD)
578K → 422K shares (−27%)
Bank of America (BAC)
904K → 923K shares (+2%)
Kroger (KR)
1.02M → 935K shares (−8%)
Textron (TXT)
455K → 551K shares (+21%)
British American Tobacco P.L.C. (BTI)
805K → 815K shares (+1%)
Novartis (NVS)
432K → 317K shares (−27%)
ONEOK INC NEW
540K → 551K shares (+2%)
TD Synnex (SNX)
156K → 176K shares (+13%)
Crown Holdings (CCK)
407K → 417K shares (+2%)
American Express (AXP)
133K → 136K shares (+2%)
Dick's Sporting Goods (DKS)
187K → 191K shares (+2%)
McKesson Corporation (MCK)
55K → 57K shares (+3%)
Verizon (VZ)
771K → 1.01M shares (+30%)
Zto Express (Cayman) (ZTO)
1.71M → 1.89M shares (+10%)
IBM (IBM)
140K → 143K shares (+2%)
Amgen (AMGN)
128K → 108K shares (−16%)
Jacobs Solutions (J)
304K → 311K shares (+2%)
Akamai Technologies (AKAM)
473K → 319K shares (−33%)
Ameriprise Financial (AMP)
79K → 81K shares (+2%)
Smith & Nephew (SNN)
1.39M → 1.25M shares (−10%)
Huntington Ingalls Industries (HII)
126K → 129K shares (+2%)